Cover Image

Handling of highly active pharmaceutical ingredients and intermediates in the pharmaceutical industry

Saved in:

Bibliographic Details
Main Author:	David Miedinger (Author)
Format:	Book
Published:	Elsevier, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Active pharmaceutical ingredients in dermatological medicines of Ukrainian pharmaceutical market
by: I. O. Vlasenko, et al.
Published: (2019)

Multicomponent Reactions for the Synthesis of Active Pharmaceutical Ingredients
by: Ángel Cores, et al.
Published: (2022)

Pharmaceutical cocrystal and their role in improving solid state properties of active pharmaceutical ingredients
by: Ameera A Radhi, et al.
Published: (2023)

Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems
by: Ruslan Safarov, et al.
Published: (2024)

Modification of the Physicochemical Properties of Active Pharmaceutical Ingredients via Lyophilization
by: Amir Taldaev, et al.
Published: (2023)

Application of Machine Learning for Predicting Bulk Behaviour of Active Pharmaceutical Ingredients
by: Martin Strachon, et al.
Published: (2023)

Research of water extraction from xenoderm as an active pharmaceutical ingredient in drugs
by: B. V. Pavliuk, et al.
Published: (2020)

Registro de insumos farmacêuticos ativos: impactos e reflexos sobre as indústrias farmoquímica e farmacêutica instaladas no Brasil | Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
by: Diva Barrio Arrepia, et al.
Published: (2015)

The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients
by: Magdalena Janczura, et al.
Published: (2022)

Consequences of new approach of chemical stability tests of active pharmaceutical ingredients (APIs)
by: Marzena eJamrógiewicz
Published: (2016)

Feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of GM1-gangliosidosis
by: Yuki Maeda, et al.
Published: (2016)

TECHNOLOGY OF OBTAINING POLYRIBOSYLRIBITOL PHOSPHATE AS AN ACTIVE PHARMACEUTICAL INGREDIENT FOR THE PRODUCTION OF POLYSACCHARIDE VACCINES
by: E. L. Salimova, et al.
Published: (2018)

Global dependence on chinese-sourced active pharmaceutical ingredients: Policy analysis and recommendations
by: R.N. Nang
Published: (2016)

Analysis of spironolactone polymorphs in active pharmaceutical ingredients and their effect on tablet dissolution profiles
by: Renata Cunha de Resende, et al.

Controlling phase transformation during milling in the pre-formulation of Active pharmaceutical Ingredients
by: Ghaidaa Sulaiman Hameed
Published: (2019)

Risk-Based Approach for Defining Retest Dates for Active Pharmaceutical Ingredients and Excipients
by: Naseem A. Charoo, et al.
Published: (2024)

Basis of optimal concentration of active pharmaceutical ingredients in combdrugs for external use with antimycotic activity
by: V. V. Luc, et al.
Published: (2018)

Promoting local production and active pharmaceutical ingredient (API) industry in low and middle income countries (LMICs): impact on medicines access and policy
by: Muhammad Akhtar Abbas Khan, et al.
Published: (2024)

On the relationship between blend state and dispersibility of adhesive mixtures containing active pharmaceutical ingredients
by: Jonas Rudén, et al.
Published: (2021)

Encapsulation of Active Pharmaceutical Ingredients in Lipid Micro/Nanoparticles for Oral Administration by Spray-Cooling
by: Carmen S. Favaro-Trindade, et al.
Published: (2021)

Formulation Strategies to Improve the Stability and Handling of Oral Solid Dosage Forms of Highly Hygroscopic Pharmaceuticals and Nutraceuticals
by: Liu Han Ng, et al.
Published: (2022)

Are antibiotics substandard in Lebanon? Quantification of active pharmaceutical ingredients between brand and generics of selected antibiotics
by: Eva Hobeika, et al.
Published: (2020)

Multifunctional nanomaterials composed entirely of active pharmaceutical ingredients for synergistically enhanced antitumor and antibacterial effects
by: Qi An, et al.
Published: (2024)

Deep Eutectic Solvents as Active Pharmaceutical Ingredient Delivery Systems in the Treatment of Metabolic Related Diseases
by: Cixin Huang, et al.
Published: (2021)

Study of base influence on the active pharmaceutical ingredients releasing from combined ointments with antimycotic action
by: V. V. Luc, et al.
Published: (2018)

Compatibility of Commonly Used Active Pharmaceutical Ingredients in a Ready-to-Use Oral Suspending Vehicle
by: Mercedeh Mansourian, et al.
Published: (2023)

Controlling Microparticle Morphology in Melt-Jet Printing of Active Pharmaceutical Ingredients through Surface Phenomena
by: Shachar Bornstein, et al.
Published: (2023)

Patents and licensing in pharmaceutical industry
by: Katerina Ancevska Netkovska, et al.
Published: (2005)

Perceptions on the risk and management of unused pharmaceuticals toward the creation of guidelines on handling and disposal
by: Marianne Uy Antonio, et al.
Published: (2016)

Integrated Purification and Formulation of an Active Pharmaceutical Ingredient via Agitated Bed Crystallization and Fluidized Bed Processing
by: Michael W. Stocker, et al.
Published: (2022)

Study of the effect of active pharmaceutical ingredients of various classes of BCS on the parameters of thermosensitive systems based on poloxamers
by: E.O. Bakhrushina, et al.
Published: (2023)

Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid-liquid separator design
by: Kuveneshan Moodley, et al.
Published: (2018)

Quality-by-Design Is a Tool for Quality Assurance in the Assessment of Enantioseparation of a Model Active Pharmaceutical Ingredient
by: Dina Aboushady, et al.
Published: (2020)

Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: A multiparametric evaluation
by: Gustavo Kenji Toko Purcino do Amaral, et al.
Published: (2024)

THEDES as a drug product intermediate for improved melt-extrusion processibility of thermally labile active ingredients
by: Magdy Mahmoud Abdelquader, et al.
Published: (2023)

Evaluation of Validation Plans and Validation Activities in Iranian Pharmaceutical Industries
by: Mohsen Dehghan-Dehnavi, et al.
Published: (2015)

A Pediatrics Utilization Study in The Netherlands to Identify Active Pharmaceutical Ingredients Suitable for Inkjet Printing on Orodispersible Films
by: J. Carolina Visser, et al.
Published: (2020)

Review of Quality Deficiencies Found in Active Pharmaceutical Ingredient Master Files Submitted to the WHO Prequalification of Medicines Programme
by: Isabel Ortega Diego, et al.
Published: (2014)

Binary Mixtures of Some Active Pharmaceutical Ingredients with Fatty Alcohols-The Criteria of Successful Eutectic Formation and Dissolution Improvement
by: Songhee Jin, et al.
Published: (2020)

FTO (Freedom to Operate) in the Pharmaceutical Industry
by: Nonaka, Hirotaka
Published: (2018)